Previous Article | Next Article 
Journal of Virology, January 2001, p. 971-978, Vol. 75, No. 2
Plum Island Animal Disease Center,
Agricultural Research Service, U.S. Department of Agriculture,
Greenport, New York 11944
Received 9 August 2000/Accepted 10 October 2000
Here we present the first complete genomic sequence of Marek's
disease virus serotype 3 (MDV3), also known as turkey herpesvirus (HVT). The 159,160-bp genome encodes an estimated 99 putative proteins
and resembles alphaherpesviruses in genomic organization and gene
content. HVT is very similar to MDV1 and MDV2 within the unique long
(UL) and unique short (US) genomic regions, where homologous genes
share a high degree of colinearity and their proteins share a high
level of amino acid identity. Within the UL region, HVT contains 57 genes with homologues found in herpes simplex virus type 1 (HSV-1), six
genes with homologues found only in MDV, and two genes (HVT068 and
HVT070 genes) which are unique to HVT. The HVT US region is 2.2 kb
shorter than that of MDV1 (Md5 strain) due to the absence of an MDV093
(SORF4) homologue and to differences at the UL/short repeat (RS)
boundary. HVT lacks a homologue of MDV087, a protein encoded at the
UL/RS boundary of MDV1 (Md5), and it contains two homologues of MDV096
(glycoprotein E) in the RS. HVT RS are 1,039 bp longer than those in
MDV1, and with the exception of an ICP4 gene homologue, the gene
content is different from that of MDV1. Six unique genes, including a homologue of the antiapoptotic gene Bcl-2, are found in the
RS. This is the first reported Bcl-2 homologue in an
alphaherpesvirus. HVT long repeats (RL) are 7,407 bp shorter than those
in MDV1 and do not contain homologues of MDV1 genes with functions
involving virulence, oncogenicity, and immune evasion. HVT lacks
homologues of MDV1 oncoprotein MEQ, CxC chemokine,
oncogenicity-associated phosphoprotein pp24, and conserved domains of
phosphoprotein pp38. These significant genomic differences in and
adjacent to RS and RL regions likely account for the differences in
host range, virulence, and oncogenicity between nonpathogenic HVT and
highly pathogenic MDV1.
Turkey herpesvirus (HVT) is a
ubiquitous, nonpathogenic virus of domestic turkeys (15,
78-80), and it is classified as the third serotype within the
Marek's disease virus (MDV) group of antigenically and genetically
related lymphotropic avian herpesviruses (15). This group
also includes MDV serotype 1 (MDV1), which is the etiologic agent of
the globally and economically significant Marek's disease in chickens
(15). MDV1 is pathogenic in chickens, causing cytolytic
infection in B cells, latent infection in T cells, and induction of
T-cell lymphoma. MDV2 is nonpathogenic or of low pathogenicity in
chickens (15).
HVT is nonpathogenic in chickens, but it does induce a viremia which is
associated with induction of protective immune responses against MDV1
(15). Chickens infected with HVT become persistently infected and maintain long-lasting immunity (15, 29, 44, 53,
80). HVT appears to replicate less efficiently in skin than does
MDV1, a phenotype that may be involved in the relatively infrequent
transmission of HVT among chickens compared to attenuated strains of
MDV1 and MDV2 (15-17).
HVT and combinations of HVT and nonpathogenic strains of MDV1 and MDV2
have been used extensively and effectively as vaccines against virulent
MDV1 since the early 1970s (15, 44, 53, 80). Other
benefits of HVT vaccines include the ability to genetically modify the
virus for expression of protective heterologous antigens and the
potential for in ovo vaccination. HVT vectors expressing genes from
Newcastle disease virus, infectious bursal disease virus, and
infectious bronchitis virus confer protective systemic immune responses
against these pathogens (19, 54, 58, 86). In ovo
vaccination of late-stage (16- to 18-day) embryos with HVT leaves newly
hatched chickens immune to challenge with pathogenic MDV1 (62,
63).
Although current vaccination strategies will effectively protect
against most MDV1 isolates, they are not completely effective against
newly emerging MDV1 strains of greater virulence (77). These strains which pose a constant threat to the poultry industry, are
characterized by higher cytolytic activity, unusual tissue tropism,
increased atrophy of lymphoid organs, immunosuppression, enhanced
capacity to transform T cells, and earlier host death (77). The genetic basis underlying differences in viral
virulence, oncogenicity, and host range among MDV strains is poorly understood.
Comparative genomics has proven useful in identifying genes with
functions involving virulence and host range. The genomes of two MDV1
strains (GA and Md5) have been sequenced (45, 74), and the
unique long and unique short (UL and US, respectively) regions of MDV2
are available (37). However, less than 30% of the HVT
genome has been sequenced (5, 41, 43, 48, 68, 83, 85).
Here we present the complete sequence of HVT strain FC-126
(Burmenester), with analysis and comparison to MDV1 and MDV2.
DNA isolation, cloning, and sequencing.
HVT strain FC-126
(Burmenester), originally isolated from the blood of an asymptomatic
turkey (79), was obtained from the American Type Culture
Collection (Manassas, Va.). The virus was propagated in primary chicken
embryo fibroblast cell culture, and viral DNA was extracted from the
cytoplasm of infected cells as previously described (76).
Random DNA fragments were obtained by incomplete enzymatic digestion
with endonucleases TaqI and AciI (New England
Biolabs, Beverly, Mass.). DNA fragments of 1.5 to 3 kbp were isolated
after separation on agarose gels, cloned into the dephosphorylated
AccI site of pUC19 plasmids, and grown in Escherichia
coli DH10B cells (Gibco BRL, Gaithersburg, Md.). Plasmids were
purified by alkaline lysis as instructed by the manufacturer (Eppendorf
5 Prime, Boulder, Colo.). DNA templates were sequenced from both ends
with M13 forward and reverse primers, using dideoxy-chain terminator
sequencing chemistries (60) and an Applied Biosystem PRISM
377 automated DNA sequencer (PE Biosystems, Foster City, Calif.). ABI
sequencing analysis software (version 3.3) was used for lane tracking
and trace extraction. Bases were called from chromatogram traces with
Phred (27), which also produced a quality file containing
a predicted probability of error at each base position.
DNA sequence analysis.
DNA sequences were assembled with
Phrap (26), using the quality files and default settings
to produce a consensus sequence which was manually edited with Consed
(33). An identical sequence was assembled using the TIGR
assembler with quality files and clone length constraints
(72). The final DNA consensus sequence represented an
average eightfold redundancy at each base position. Gap closure was
achieved by primer walking of gap-spanning clones and sequencing of PCR
products. A total of 5,074 usable traces were assembled into a
140,525-bp contig by bidirectional sequencing of random clones and 28 PCR products. The assembled contig had an estimated error rate of
<0.03% and no evidence of polymorphism using Polyphred analysis
(26). Because the terminal and internal UL repeats (TRL
and IRL, respectively) are identical and the internal and terminal US
repeats (IRS and TRS, respectively) are identical, the coverage
(redundancy at each base position) of the internal long and short
repeats was approximately doubled. The assembled contig contained 663 bp of the TRS, all of the UL, IRL, IRS, and US, and 395 bp of the TRS
(i.e., the full genome length minus the length of the TRL and IRL). TRL
and TRS sequences were assembled separately with clones containing the
TRL/UL and US/TRS junctions and overlapping clones, using clone length
constraints and position as provided by the computer assembly programs.
The TRL and IRL contigs were then joined to the main contig at the
overlapping region in the TRL/UL and US/TRS boundaries, thus providing
the complete genome. The predicted restriction map for HVT matched previously published data (13). For descriptive purposes,
we have presented HVT in a linearized fashion as described by Dolan et
al. (24). Genome DNA composition, structure, repeats, and restriction enzyme patterns were analyzed as previously described (2). Open reading frames (ORFs) encoding proteins of Nucleotide sequence accession number.
The HVT genome
sequence has been deposited in GenBank under accession no. AF291866.
Genome organization.
The HVT genome is 159,160 bp long and
contains a 47.5% G+C base composition. HVT is organized in the same
overall manner as are other alphaherpesviruses (55) (Fig.
1). UL and US regions are 111,868 and
8,617 bp in length, respectively. Each unique region is bounded by
identical inverted repeats. The TRL and IRL are 5,658 bp, and the IRS
and TRS are 13,303 bp. As with other herpesviruses, the G+C content in
the repeat regions is higher than in unique regions (55% in repeats
versus 45% in unique regions) (21, 32, 73). HVT contains
no retrovirus long terminal repeat sequences as have been described for
cell culture-adapted MDV1 strains (36, 38, 39, 45). The
assembled HVT sequence contains a 251-bp sequence that is identical at
each terminus and at the IRL/IRS junction. This repeat contains
sequences similar to alphaherpesvirus
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.971-978.2001
The Genome of Turkey Herpesvirus
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
60
amino acids with a methionine start codon (70, 71)
were evaluated for coding potential using the Hexamer
(ftp.sanger.ac.uk/pub/rd), Framefinder
(www.hgmp.mrc.ac.uk /~gslater/ESTate/), and Glimmer (59) computer programs. Other criteria included similarity
to other herpesvirus or cellular proteins and compact gene arrangement with little gene overlap (21, 73). Homology searches were conducted using BLAST (3), PSIBLAST (4),
FASTA (52), BLIMPS (75), and HMMER
(69) programs with the Prosite, Pfam, Prodom, Sbase,
Blocks, Domo, and GenBank databases (14). GCG
(22), MEMSAT (40), and SAPS (10)
programs were used for gene analysis.
RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
-type sequences
(42) and includes 17 copies of the GGGTTA motif found in MDV1 (64 copies), human herpesvirus 6, and eukaryotic telomers
(42, 74). In addition, a 266-bp identical inverted repeat
is located adjacent to the TRL at positions 5910 to 6175 and near the
IRL at positions 116856 to 117121 (Fig. 1). A 656-bp unique sequence
(117122 to 117177) separates the second 266-bp repeat from the IRL
(Fig. 1).
View larger version (52K):
[in a new window]
FIG. 1.
Linear map of the HVT genome. Genes (colored arrows) are
numbered from left to right based on positions of methionine initiation
codons and transcribed in the direction indicated. Genes included in
different genomic regions are defined by the color key. Nucleotide
positions are indicated below the map. Spliced genes are indicated by
asterisks.
Gene characterization.
HVT contains 397 ORFs of 60 to 2,164 codons, of which 99 are estimated to be functional genes (Fig.
2).
Seventy-five genes are present as single copies and initiate within
unique regions. Two genes initiate within the US region but are
partially located within repeat regions (HVT083 and HVT092). Twenty-two
genes initiate and are completely located within repeat regions. HVT
gene products are most similar to homologues from MDV1 (36 to 82%
amino acid identity) and MDV2 (34 to 81% amino acid identity). Among
nonavian herpesviruses, ORFs of equine herpesviruses 1 and 4 are most
similar to those of HVT (27 to 62% amino acid identity).
|
UL region. The UL region, extending from nucleotide positions 5910 to 117777, contains 67 probable genes (Fig. 1 and 2). HVT008 to HVT063 represent 62% of the HVT genome and are colinear with genes UL1 to UL54 of herpes simplex virus type 1 (HSV-1) and MDV013 to MDV068 of MDV1 (74). Predicted proteins are 37 to 82% identical to MDV1 homologues. Those with the greatest (>70%) amino acid identity to MDV1 proteins correspond to capsid proteins (HVT025 and HVT026), viral replication proteins (HVT012, HVT016, HVT022, HVT037, HVT038, HVT039, HVT047, and HVT048), membrane proteins (HVT035, HVT052, and HVT053), and phosphoproteins (HVT010 and HVT061). These proteins are also the most conserved in comparison with MDV2 and other nonavian herpesviruses. HVT tegument proteins are the least conserved within the UL, with seven (HVT018, HVT021, HVT028, HVT044, HVT054, HVT055, and HVT057) sharing less than 51% amino acid identity with MDV1 homologues. Other, less conserved UL proteins include homologues of HSV virion surface glycoprotein L (HVT008), glycoprotein K (HVT062), and proteins of unknown function (HVT030, HVT051, HVT064, HVT065, and HVT066). HVT044 (large tegument protein) is 230 amino acids shorter than its MDV1 homologue due to the lack of a highly repetitive central proline-rich domain.
Six predicted HVT genes located at the ends of the UL region are MDV specific. The absence of HVT006 (MDV011), HVT007 (MDV012), HVT064 and HVT067 (MDV069), HVT069 (MDV072), and HVT071 (MDV073) (Fig. 2) in non-MDV alphaherpesviruses suggests an avian host range function, perhaps involving some aspects of lymphotropism. On the left end, HVT lacks homologues of MDV008 (pp24) and MDV009, a gene of unknown function (74). On the right end, HVT contains two novel genes (HVT068 and HVT070) which are absent in MDV1 and encodes two homologues (HVT064 and HVT067) of MDV069. HVT005 is similar to eukaryotic and viral lipases (GenBank accession no. AF007578 and L43561) and shares 41 to 45% identity with MDV homologues (6, 74). HVT005 contains the serine active site at amino acid position 287 within the lipase signature motif (IxxIGHSxS, Prosite PS00120) and conserved cysteines involved in disulfide bond formation (amino acid positions 387 and 397). The region between amino acids 120 and 265 is similar to corresponding regions in eukaryotic lipases such as phospholipase A1 (26% over 154 amino acids). Similarity to predicted proteins from MDV1, MDV2, and fowl adenovirus extends beyond this region, suggesting the presence of additional virus-specific domains. The presence of a signal peptide in the amino-terminal domain and a transmembrane domain at amino acid positions 479 to 501 suggests that HVT005 may be membrane localized. HVT005 may perform host range functions involving alteration of host lipid metabolism and/or modification of second-messenger signaling pathways (1, 23, 31, 35, 50, 61, 66). Altered lipid metabolism has been observed both in vivo and in cell cultures during MDV infection (28, 34).US region. The US region, extending from positions 136990 to 145606, has been previously sequenced (83). This region encodes 10 likely genes (HVT083 to HVT092), of which 7 are homologues of the HSV-1 genes US1, US2, US3, US6, US7, US8, and US10. Proteins encoded in the HVT US region are 39 to 66% identical to their homologues in MDV1 and overall are less conserved (48%) than those in the UL region (61%). The arrangement of genes in the HVT US region is similar to that in MDV1 and MDV2 (37, 74), including the inversion-translocation of the UL10 homologue, compared to HSV-1 (11, 21, 49, 56, 73, 87). HVT087, a homologue of MDV090, is found only in MDV. In addition, an HVT-specific gene of unknown function (HVT084) is found near the IRS/US boundary. HVT lacks a homologue of MDV093 (SORF4), a gene found in MDV1.
The US short repeat (RS) junction region is variable among MDV1, MDV2, and HVT (11, 37, 74, 83). Unlike MDV1 and MDV2, the carboxyl terminus of the HVT US8 gene homologue (glycoprotein E [gE] gene) is duplicated and inverted to the other end of the US. The presence of two copies of the gE ORF does not imply that the virus expresses two forms of gE. Thus, the HVT US/RS boundaries are located within the US8 homologues (HVT083 and HVT092 genes) and reduce the size of the US compared to MDV1 and MDV2. Duplication of US genes and resulting changes in US/RS boundary position has been noted between strains of MDV1 and with other herpesviruses (11, 20, 74). Like MDV2, HVT lacks a homologue of the MDV087 (SORF2) gene. SORF2 is nonessential for MDV1 replication in cell culture, but it is duplicated in the very virulent MDV1 strain Md5 (11, 51, 74). Although the function of this gene is unknown, its presence in fowlpox virus and fowl adenovirus suggests a significant avian host range function (2, 65).RL. The RL are 5,658 bp in length and are located at nucleotide positions 252 to 5909 and 117778 to 123435. HVT RL are 7,407 bp shorter than MDV1 RL and lack homologues of all MDV1 RL genes. Each RL contains four possible HVT-specific genes, which predict proteins of unknown function (HVT001 to HVT004 and HVT072 to HVT075). Although there are no other readily identifiable genes in this region based on our criteria, the RL does contain 21 ORFs of more than 60 codons. Thus, additional genes may be present.
Most notably, and consistent with its nonpathogenic phenotype, HVT lacks homologues of all MDV1 RL proteins with putative functions involving viral virulence, host range, and oncogenicity. HVT contains no homologues of the Marek's EcoRI Q protein (MEQ) (MDV005 and MDV076), which is associated with cellular transformation and oncogenicity (45, 74). In addition, HVT lacks pp24 (MDV008) and conserved domains of pp38 (MDV073), phosphoproteins associated with cellular transformation (18, 81, 88). The functional homology of HVT071 to pp38 is unclear. HVT071 lacks the amino terminus (75 amino acids) and a centrally located (22-amino-acid) conserved region containing a DLLVEAE motif found in pp38 and pp24 (74). Moreover, recent experiments have shown that deletion of this putative gene from the HVT genome has no effect on viral growth or virulence (12). HVT lacks a homologue of the MDV1 CxC chemokine (MDV003 and MDV078) (74) and the 132-bp repeat region whose expansion has been associated with altered viral transcription and loss of oncogenicity (7, 9, 30, 47, 57, 67).RS. The short repeat regions (RS) are 13,303 bp and are located at nucleotide positions 123687 to 136989 and 145607 to 158909. Each RS encode seven possible genes, of which five lack homology to other known genes (Fig. 1 and 2). HVT080 and HVT095 encode homologues of the HSV-1 major immediate-early trans-activating protein ICP4. These genes, which encode proteins of 2,164 amino acids, comprise over 48% of the RS. Interestingly, HVT080 and HVT095 contain an 810-amino-acid amino-terminal extension which is absent in ICP4 homologues of other nonavian alphaherpesviruses. A similarly sized ICP4 homologue has been previously found in MDV1 and predicted to exist in HVT (74, 84). HVT lacks identifiable homologues of immediate-early proteins ICP0, which is nonessential for replication of HSV-1 in cell culture (55), and ICP47, a host range protein which blocks HSV-1 antigen presentation on infected cells (82). HVT also lacks identifiable homologues of MDV085, a protein of unknown function, and MDV086, a gene present in a region transcribed during viral latency (74).
HVT079 and HVT096 encode identical 162-amino-acid proteins with significant similarity (66% amino acid identity) to the quail Nr13 protein, a homologue of Bcl-2 (Fig. 3) (46). Amino acid identity occurs over the entire length of the protein and includes Bcl-2 BH1, BH2, and BH3 domains and a novel form of the BH4 domain (46). HVT079 and HVT096 lack the 15-amino-acid carboxyl-terminal transmembrane domain present in Nr13 and in other mammalian Bcl-2 homologues. Although all sequenced gammaherpesvirus genomes encode Bcl-2 homologues (8), HVT079 and HVT096 represent the first Bcl-2 homologues found in an alphaherpesvirus.
|
Conclusions. HVT resembles other alphaherpesviruses in genome organization and gene content. A close relationship among MDV serotypes is evident by the high degree of amino acid identity of protein homologues and by the presence of MDV-specific proteins. Significant genomic differences occur between HVT and MDV1 in and adjacent to RL and RS, and these may account for differences in tissue tropism, host range, and the nonpathogenic phenotype of HVT (15). HVT lacks putative MDV1 virulence and host range genes, including MEQ, pp24, pp38, CxC chemokine, MDV087 (SORF2), and MDV093 (SORF4). There are 13 HVT-specific genes, which include a Bcl-2 homologue. Thus, comparative analysis of nonpathogenic HVT and MDV2 and virulent MDV1 genomes enhances our overall understanding of MDV virulence and host range. This information will permit the engineering of novel MDV vaccine viruses and avian expression vectors with enhanced efficacy and greater versatility.
| |
ACKNOWLEDGMENTS |
|---|
We thank A. Ciupryk and G. Smoliga for excellent technical assistance and W. H. Martinez, F. P. Horn, and R. G. Breeze for their interest and encouragement.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Plum Island Animal Disease Center, P.O. Box 848, Greenport, NY 11944-0848. Phone: (631) 323-3330. Fax: (631) 323-3044. E-mail: gkutish{at}asrr.arsusda.gov.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
|
|---|
| 1. | AbuBakar, S., I. Boldogh, and T. Albrecht. 1990. Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C. Biochem. Biophys. Res. Commun. 166:953-959[CrossRef][Medline]. |
| 2. |
Afonso, C. L.,
E. R. Tulman,
Z. Lu,
L. Zsak,
G. F. Kutish, and D. L. Rock.
2000.
The genome of fowlpox virus.
J. Virol.
74:3815-3831 |
| 3. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[CrossRef][Medline]. |
| 4. |
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 5. | Bandyopadhyay, P. K. 1989. Characterization of a highly transcribed DNA region of herpesvirus of turkeys. Gene 79:361-367[CrossRef][Medline]. |
| 6. | Becker, Y., Y. Asher, E. Tabor, I. Davidson, and M. Malkinson. 1994. Open reading frames in a 4556 nucleotide sequence within MDV-1 BamHI-D DNA fragment: evidence for splicing of mRNA from a new viral glycoprotein gene. Virus Genes 8:55-69[CrossRef][Medline]. |
| 7. | Becker, Y., E. Tabor, Y. Asher, I. Davidson, M. Malkinson, and R. L. Witter. 1993. PCR detection of amplified 132 bp repeats in Marek's disease virus type 1 (MDV-1) DNA can serve as an indicator for critical genomic rearrangement leading to the attenuation of virus virulence. Virus Genes 7:277-287[CrossRef][Medline]. |
| 8. |
Bellows, D. S.,
B. N. Chau,
P. Lee,
Y. Lazebnik,
W. H. Burns, and J. M. Hardrick.
2000.
Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.
J. Virol.
74:5024-5031 |
| 9. |
Bradley, G.,
G. Lancz,
A. Tanaka, and M. Nonoyama.
1989.
Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed with BamHI-H.
J. Virol.
63:4129-4135 |
| 10. |
Brendel, V.,
P. Bucher,
I. R. Nourbakhsh,
B. E. Blaisdell, and S. Karlin.
1992.
Methods and algorithms for statistical analysis of protein sequences.
Proc. Natl. Acad. Sci. USA
89:2002-2006 |
| 11. | Brunovskis, P., and L. F. Velicer. 1995. The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology 206:324-338[CrossRef][Medline]. |
| 12. | Bublot, M., E. Laplace, and J.-C. Audonnet. 1999. Non-essential loci in the BamHI-1 and -F fragments of the HVT FC126 genome. Acta Virol. 43:181-185[Medline]. |
| 13. |
Buckmaster, A. E.,
S. D. Scott,
M. J. Sanderson,
M. E. G. Boursnell,
N. L. J. Ross, and M. M. Binns.
1988.
Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification.
J. Gen. Virol.
69:2033-2042 |
| 14. |
Burks, C.
1999.
Molecular biology database list.
Nucleic Acids Res.
27:1-9 |
| 15. | Calnek, B. W., and R. L. Witter (ed.). 1991. Marek's disease, 9th ed. Iowa State University Press, Ames, Iowa. |
| 16. | Cho, B. R. 1974. Horizontal transmission of turkey herpesvirus to chickens. IV. Viral maturation in the feather follicle epithelium. Avian Dis. 19:136-141[CrossRef]. |
| 17. | Cho, B. R., and S. G. Kenzy. 1975. Horizontal transmission of turkey herpesvirus to chickens. III. Transmission in three different lines of chickens. Poult. Sci. 54:109-115[Medline]. |
| 18. |
Cui, Z.,
L. F. Lee,
J.-L. Liu, and H.-J. Kung.
1991.
Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.
J. Virol.
65:6509-6515 |
| 19. | Darteil, R., M. Bublot, E. Laplace, J.-F. Bouquet, J.-C. Audonnet, and M. Riviere. 1995. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211:481-490[CrossRef][Medline]. |
| 20. |
Davidson, A. J., and D. J. McGeoch.
1986.
Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus.
J. Gen. Virol.
67:597-611 |
| 21. |
Davison, A. J., and J. E. Scott.
1986.
The complete DNA sequence of varicella-zoster virus.
J. Gen. Virol.
67:1759-1816 |
| 22. | Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395. |
| 23. | Dimitrov, T., P. Krajcsi, T. W. Hermiston, A. E. Tollefson, M. Hannink, and W. S. M. Wold. 1997. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J. Virol. 71:2830-2837[Abstract]. |
| 24. |
Dolan, A.,
F. E. Jamieson,
C. Cunningham,
B. C. Barnett, and D. J. McGeoch.
1998.
The genome sequence of herpes simplex virus type 2.
J. Virol.
72:2010-2021 |
| 25. | Ewert, D., and J. Duhadaway. 1999. Inhibition of apoptosis by Marek's disease viruses. Acta Virol. 43:133-135[Medline]. |
| 26. |
Ewing, B., and P. Green.
1998.
Base-calling of automated sequencer traces using Phred. II. Error probabilities.
Genome Res.
8:186-194 |
| 27. |
Ewing, B.,
L. Hillier,
M. C. Wendl, and P. Green.
1998.
Base-calling of automated sequencer traces using Phred. I. Accuracy assessment.
Genome Res.
8:175-185 |
| 28. | Fabricant, C. G., D. P. Hajjar, C. R. Minick, and J. Fabricant. 1981. Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Am. J. Pathol. 105:176-184[Abstract]. |
| 29. | Fabricant, J., B. W. Calnek, and K. A. Schat. 1982. The early pathogenesis of turkey herpesvirus infection in chickens and turkeys. Avian Dis. 26:257-264[CrossRef][Medline]. |
| 30. |
Fukuchi, K.,
A. Tanaka,
L. W. Schierman,
R. L. Witter, and M. Nonoyama.
1985.
The structure of Marek's disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA.
Proc. Natl. Acad. Sci. USA
82:751-754 |
| 31. |
Geras-Raaka, E.,
L. Arvanitakis,
C. Bais,
E. Cesarman,
E. A. Mesri, and M. C. Gershengorn.
1998.
Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture.
J. Exp. Med.
187:801-806 |
| 32. | Gompels, U. A., J. Nicholas, G. Lawrence, M. Jones, B. J. Thomson, M. E. D. Martin, S. Efstathiou, M. Craxton, and H. A. Macaulay. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51[CrossRef][Medline]. |
| 33. | Gordon, D., C. Abajian, and P. Green. 1998. Consed: a graphical tool for sequence finishing. Genome Res. 8:192-202. |
| 34. | Hajjar, D. P., C. G. Fabricant, C. R. Minick, and J. Fabricant. 1986. Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am. J. Pathol. 122:62-70[Abstract]. |
| 35. |
Higgs, H. N., and J. A. Glomset.
1996.
Purification and properties of a phosphatidic acid-preferring phospholipase A1 from bovine testis.
J. Biol. Chem.
271:10874-10883 |
| 36. | Isfort, R. J., Z. Qian, D. Jones, R. F. Silva, R. Witter, and H.-J. Kung. 1994. Integration of multiple chicken retroviruses into multiple chicken herpesviruses: herpesviral gD as a common target of integration. Virology 203:125-133[CrossRef][Medline]. |
| 37. | Jang, H.-K., M. Ono, T.-J. Kim, Y. Izumiya, A. M. Damiani, T. Matsumura, M. Niikura, C. Kai, and T. Mikami. 1998. The genetic organization and transcriptional analysis of the short unique region in the genome of nononcogenic Marek's disease virus serotype 2. Virus Res. 58:137-147[CrossRef][Medline]. |
| 38. | Jones, D., P. Brunovskis, R. Witter, and H.-J. Kung. 1996. Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone. J. Virol. 70:2460-2467[Abstract]. |
| 39. |
Jones, D.,
R. Isfort,
R. Witter,
R. Kost, and H.-J. Kung.
1993.
Retroviral insertions into a herpesvirus are clustered at the junctions of the short repeat and short unique sequences.
Proc. Natl. Acad. Sci. USA
90:3855-3859 |
| 40. | Jones, D. T., W. R. Taylor, and J. M. Thornton. 1994. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33:3038-3049[CrossRef][Medline]. |
| 41. | Kato, A., I. Sato, T. Ihara, S. Ueda, A. Ishihama, and K. Hirai. 1989. Homologies between herpesvirus of turkey and Marek's disease virus type-1 DNAs within two co-linearly arranged open reading frames, one encoding glycoprotein A. Gene 84:399-405[CrossRef][Medline]. |
| 42. |
Kishi, M.,
H. Harada,
M. Takahashi,
A. Tanaka,
M. Hayashi,
M. Nonoyama,
S. F. Josephs,
A. Buchbinder,
F. Schachter,
D. V. Ablashi,
F. Wong-Staal,
S. Z. Salahuddin, and R. C. Gallo.
1988.
A repeat sequence, GGGTTA, is shared by DNA of human herpesvirus 6 and Marek's disease virus.
J. Virol.
62:4824-4827 |
| 43. | Kopacek, J., L. Klucar, D. Koptidesova, J. Turna, J. Pastorek, and V. Zelnik. 2000. Nucleotide sequence of the gene encoding the major capsid protein of herpesvirus of turkey. Virus Genes 20:107-115[CrossRef][Medline]. |
| 44. | Lee, K. 1980. Long term effects of Marek's disease vaccination with cell-free herpesvirus of turkey and age at debeaking on performance and mortality of white leghorns. Poult. Sci. 59:2002-2007[Medline]. |
| 45. |
Lee, L. F.,
P. Wu,
D. Sui,
D. Ren,
J. Kamil,
H. J. Kung, and R. L. Witter.
2000.
The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.
Proc. Natl. Acad. Sci. USA
97:6091-6096 |
| 46. |
Lee, R.-M.,
G. Gillet,
J. Burnside,
S. J. Thomas, and P. Neiman.
1999.
Role of Nr13 in regulation of programmed cell death in the bursa of Fabricius.
Genes Dev.
13:718-728 |
| 47. |
Maotani, K.,
A. Kanamori,
K. Ikuta,
S. Ueda,
S. Kato, and K. Hirai.
1986.
Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage.
J. Virol.
58:657-660 |
| 48. |
Martin, S. L.,
D. I. Aparisio, and P. K. Bandyopadhyay.
1989.
Genetic and biochemical characterization of the thymidine kinase gene from herpesvirus of turkeys.
J. Virol.
63:2847-2852 |
| 49. | McGeoch, D. J., A. Dolan, S. Donald, and F. J. Rixon. 1985. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J. Mol. Biol. 181:1-13[CrossRef][Medline]. |
| 50. |
Nagai, Y.,
J. Aoki,
T. Sato,
K. Amano,
Y. Matsuda,
H. Arai, and K. Inoue.
1999.
An alternative splicing form of phosphatidylserine-specific phospholipase A1 that exhibits lysophosphatidylserine-specific lysophospholipase activity in humans.
J. Biol. Chem.
274:11053-11059 |
| 51. |
Parcells, M. S.,
A. S. Anderson,
J. L. Cantello, and R. W. Morgan.
1994.
Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames.
J. Virol.
68:8239-8253 |
| 52. | Pearson, W. R. 1990. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol. 183:63-98[Medline]. |
| 53. | Purchase, H. G., W. Okazaki, and B. R. Burmester. 1972. Long-term field trials with the herpesvirus of turkeys vaccine against Marek's disease. Avian Dis. 16:57-71[CrossRef][Medline]. |
| 54. | Reddy, S. K., J. M. Sharma, J. Ahmad, D. N. Reddy, J. K. McMillen, S. M. Cook, M. A. Wild, and R. D. Schwartz. 1996. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 14:469-477[CrossRef][Medline]. |
| 55. | Roizman, B., and A. E. Sears. 1996. Herpes simplex viruses and their replication, p. 2231-2295. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, vol. 2. Lippincott-Raven, Philadelphia, Pa. |
| 56. |
Ross, L. J. N.,
M. M. Binns, and J. Pastorek.
1991.
DNA sequence and organization of genes in a 5.5 kbp EcoRI fragment mapping in the short unique segment of Marek's disease virus (strain RB1B).
J. Gen. Virol.
72:949-954 |
| 57. | Ross, N., M. M. Binns, M. Sanderson, and K. A. Schat. 1993. Alterations in DNA sequence and RNA transcription of the BamHI-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus. Virus Genes 7:33-51[CrossRef][Medline]. |
| 58. | Ross, N., G. O'Sullivan, and F. Coudert. 1996. Influence of chicken genotype on protection against Marek's disease by a herpesvirus of turkeys recombinant expressing the glycoprotein B (gB) of Marek's disease virus. Vaccine 14:187-189[CrossRef][Medline]. |
| 59. |
Salzberg, S. L.,
A. L. Delcher,
S. Kasif, and O. White.
1998.
Microbial gene identification using interpolated Markov models.
Nucleic Acids Res.
26:544-548 |
| 60. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 61. |
Sato, T.,
J. Aoki,
Y. Nagai,
N. Dohmae,
K. Takio,
T. Doi,
H. Arai, and K. Inoue.
1997.
Serine phospholipid-specific phospholipase A that is secreted from activated platelets.
J. Biol. Chem.
272:2192-2198 |
| 62. | Sharma, J. M. 1987. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development. Avian Dis. 31:570-576[CrossRef][Medline]. |
| 63. | Sharma, J. M., and B. R. Burmester. 1982. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis. 26:134-149[CrossRef][Medline]. |
| 64. | Sharma, J. M., L. F. Lee, and P. S. Wakenell. 1984. Comparative viral, immunologic, and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch. Am. J. Vet. Res. 45:1619-1623[Medline]. |
| 65. | Sheppard, M., W. Werner, E. Tsatas, R. McCoy, S. Prowse, and M. Johnson. 1998. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 143:915-930[CrossRef][Medline]. |
| 66. | Shibutani, T., T. M. Johnson, Z.-X. Yu, V. J. Ferrans, J. Moss, and S. E. Epstein. 1997. Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J. Clin. Investig. 100:2054-2061[Medline]. |
| 67. |
Silva, R. F., and R. L. Witter.
1985.
Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.
J. Virol.
54:690-696 |
| 68. | Smith, G. D., V. Zelnik, and L. J. N. Ross. 1995. Gene organization in herpesvirus of turkeys: identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology 207:205-216[CrossRef][Medline]. |
| 69. |
Sonnhammer, E. L. L.,
S. R. Eddy,
E. Birney,
A. Bateman, and R. Durbin.
1998.
Pfam: multiple sequence alignments and HMM-profiles of protein domains.
Nucleic Acids Res.
26:320-322 |
| 70. |
Staden, A., and A. D. McLachlan.
1982.
Codon preference and its use in identifying protein coding regions in long DNA sequences.
Nucleic Acids Res.
10:141-156 |
| 71. |
Staden, R.
1982.
An interactive graphics program for comparing and aligning nucleic acid and amino acid sequences.
Nucleic Acids Res.
10:2951-2961 |
| 72. | Sutton, G. G., O. White, M. D. Adams, and A. R. Kerlavage. 1995. TIGR assembler: a new tool for assembling large shotgun sequencing projects. Genome Sci. Technol. 1:9-19. |
| 73. | Telford, E. A. R., M. S. Watson, K. McBride, and A. J. Davison. 1992. The DNA sequence of equine herpesvirus-1. Virology 189:304-316[CrossRef][Medline]. |
| 74. |
Tulman, E. R.,
C. L. Afonso,
Z. Lu,
L. Zsak,
D. L. Rock, and G. F. Kutish.
2000.
The genome of a very virulent Marek's disease virus.
J. Virol.
74:7980-7988 |
| 75. |
Wallace, J. C., and S. Henikoff.
1991.
PATMAT: a searching and extraction program for sequence, pattern and block queries and databases.
CABIOS
8:249-254 |
| 76. | Wesley, R. D., and A. E. Tuthill. 1984. Genome relatedness among African swine fever virus field isolates by restriction endonuclease analysis. Prev. Vet. Med. 2:53-62. |
| 77. | Witter, R. L. 1997. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163[CrossRef][Medline]. |
| 78. | Witter, R. L. 1972. Turkey herpesvirus: lack of oncogenicity for turkeys. Avian Dis. 16:666-670[CrossRef][Medline]. |
| 79. | Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. 1970. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:525-538[Medline]. |
| 80. | Witter, R. L., and J. J. Solomon. 1972. Experimental infection of turkeys and chickens with a herpesvirus of turkeys (HVT). Avian Dis. 16:34-44[CrossRef][Medline]. |
| 81. | Xie, Q., A. S. Anderson, and R. W. Morgan. 1996. Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. J. Virol. 70:1125-1131[Abstract]. |
| 82. | York, I. A., C. Roop, D. W. Andrews, S. R. Riddell, F. L. Graham, and D. C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535[CrossRef][Medline]. |
| 83. |
Zelnik, V.,
R. Darteil,
J. C. Audonnet,
G. D. Smith,
M. Riviere,
J. Pastorek, and L. J. N. Ross.
1993.
The complete sequence and gene organization of the short unique region of herpesvirus of turkeys.
J. Gen. Virol.
74:2151-2162 |
| 84. | Zelnik, V., J. Kopacek, O. Rejholcova, P. Kabat, and J. Pastorek. 1996. ICP4 homologues of both Marek's disease virus and herpesvirus of turkeys are larger than their alphaherpesvirus counterparts, p. 164-169. In R. F. Silva, H. H. Cheng, P. M. Coussens, L. F. Lee, and L. F. Velicer (ed.), Current research on Marek's disease. American Association of Avian Pathologists, Kennett Square, Pa. |
| 85. |
Zelnik, V.,
N. L. J. Ross, and J. Pastorek.
1994.
Characterization of proteins encoded by the short unique region of herpesvirus of turkey's by in vitro expression.
J. Gen. Virol.
75:2747-2753 |
| 86. |
Zelnik, V.,
P. Tyers,
G. D. Smith,
C.-L. Jiang, and N. L. J. Ross.
1995.
Structure and properties of a herpesvirus of turkeys recombinant in which US1, US10 and SORF3 genes have been replaced by a lacZ expression cassette.
J. Gen. Virol.
76:2903-2907 |
| 87. |
Zhang, G., and D. P. Leader.
1990.
The structure of the pseudorabies virus genome at the end of the inverted repeat sequences proximal to the junction with the short unique region.
J. Gen. Virol.
71:2433-2441 |
| 88. | Zhu, G.-S., A. Iwata, M. Gong, S. Ueda, and K. Hirai. 1994. Marek's disease virus type 1-specific phosphorylated proteins pp38 and pp24 with common amino acid termini are encoded from the opposite junction regions between the long unique and inverted repeat sequences of viral genome. Virology. 200:816-820[CrossRef][Medline]. |
Journal of Virology, January 2001, p. 971-978, Vol. 75, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.971-978.2001
This article has been cited by other articles:
-
Yao, Y., Zhao, Y., Smith, L. P., Watson, M., Nair, V.
(2009). Novel MicroRNAs (miRNAs) Encoded by Herpesvirus of Turkeys: Evidence of miRNA Evolution by Duplication. J. Virol.
83: 6969-6973
[Abstract] [Full Text] -
Ushijima, Y., Koshizuka, T., Goshima, F., Kimura, H., Nishiyama, Y.
(2008). Herpes Simplex Virus Type 2 UL56 Interacts with the Ubiquitin Ligase Nedd4 and Increases Its Ubiquitination. J. Virol.
82: 5220-5233
[Abstract] [Full Text] -
Cooray, S., Bahar, M. W., Abrescia, N. G. A., McVey, C. E., Bartlett, N. W., Chen, R. A.-J., Stuart, D. I., Grimes, J. M., Smith, G. L.
(2007). Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J. Gen. Virol.
88: 1656-1666
[Abstract] [Full Text] -
Burnside, J., Bernberg, E., Anderson, A., Lu, C., Meyers, B. C., Green, P. J., Jain, N., Isaacs, G., Morgan, R. W.
(2006). Marek's Disease Virus Encodes MicroRNAs That Map to meq and the Latency-Associated Transcript.. J. Virol.
80: 8778-8786
[Abstract] [Full Text] -
Thureen, D. R., Keeler, C. L. Jr.
(2006). Psittacid herpesvirus 1 and infectious laryngotracheitis virus: comparative genome sequence analysis of two avian alphaherpesviruses.. J. Virol.
80: 7863-7872
[Abstract] [Full Text] -
Baigent, S. J., Petherbridge, L. J., Smith, L. P., Zhao, Y., Chesters, P. M., Nair, V. K.
(2006). Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease.. J. Gen. Virol.
87: 769-776
[Abstract] [Full Text] -
Kamil, J. P., Tischer, B. K., Trapp, S., Nair, V. K., Osterrieder, N., Kung, H.-J.
(2005). vLIP, a Viral Lipase Homologue, Is a Virulence Factor of Marek's Disease Virus. J. Virol.
79: 6984-6996
[Abstract] [Full Text] -
Gimeno, I. M., Witter, R. L., Hunt, H. D., Reddy, S. M., Lee, L. F., Silva, R. F.
(2005). The pp38 Gene of Marek's Disease Virus (MDV) Is Necessary for Cytolytic Infection of B Cells and Maintenance of the Transformed State but Not for Cytolytic Infection of the Feather Follicle Epithelium and Horizontal Spread of MDV. J. Virol.
79: 4545-4549
[Abstract] [Full Text] -
Lupiani, B., Lee, L. F., Cui, X., Gimeno, I., Anderson, A., Morgan, R. W., Silva, R. F., Witter, R. L., Kung, H.-J., Reddy, S. M.
(2004). Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. USA
101: 11815-11820
[Abstract] [Full Text] -
Cui, X., Lee, L. F., Reed, W. M., Kung, H.-J., Reddy, S. M.
(2004). Marek's Disease Virus-Encoded vIL-8 Gene Is Involved in Early Cytolytic Infection but Dispensable for Establishment of Latency. J. Virol.
78: 4753-4760
[Abstract] [Full Text] -
Kut, E., Rasschaert, D.
(2004). Assembly of Marek's disease virus (MDV) capsids using recombinant baculoviruses expressing MDV capsid proteins. J. Gen. Virol.
85: 769-774
[Abstract] [Full Text] -
Laidlaw, S. M., Skinner, M. A.
(2004). Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of Fowlpox virus, with those of virulent American and European viruses. J. Gen. Virol.
85: 305-322
[Abstract] [Full Text] -
Silva, R. F., Reddy, S. M., Lupiani, B.
(2004). Expansion of a Unique Region in the Marek's Disease Virus Genome Occurs Concomitantly with Attenuation but Is Not Sufficient To Cause Attenuation. J. Virol.
78: 733-740
[Abstract] [Full Text] -
Klupp, B. G., Hengartner, C. J., Mettenleiter, T. C., Enquist, L. W.
(2004). Complete, Annotated Sequence of the Pseudorabies Virus Genome. J. Virol.
78: 424-440
[Abstract] [Full Text] -
Levy, A. M., Izumiya, Y., Brunovskis, P., Xia, L., Parcells, M. S., Reddy, S. M., Lee, L., Chen, H.-W., Kung, H.-J.
(2003). Characterization of the Chromosomal Binding Sites and Dimerization Partners of the Viral Oncoprotein Meq in Marek's Disease Virus-Transformed T Cells. J. Virol.
77: 12841-12851
[Abstract] [Full Text] -
Perelygina, L., Zhu, L., Zurkuhlen, H., Mills, R., Borodovsky, M., Hilliard, J. K.
(2003). Complete Sequence and Comparative Analysis of the Genome of Herpes B Virus (Cercopithecine Herpesvirus 1) from a Rhesus Monkey. J. Virol.
77: 6167-6177
[Abstract] [Full Text] -
Fragnet, L., Blasco, M. A., Klapper, W., Rasschaert, D.
(2003). The RNA Subunit of Telomerase Is Encoded by Marek's Disease Virus. J. Virol.
77: 5985-5996
[Abstract] [Full Text] -
Cuconati, A., White, E.
(2002). Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev.
16: 2465-2478
[Full Text] -
Tsukamoto, K., Saito, S., Saeki, S., Sato, T., Tanimura, N., Isobe, T., Mase, M., Imada, T., Yuasa, N., Yamaguchi, S.
(2002). Complete, Long-Lasting Protection against Lethal Infectious Bursal Disease Virus Challenge by a Single Vaccination with an Avian Herpesvirus Vector Expressing VP2 Antigens. J. Virol.
76: 5637-5645
[Abstract] [Full Text] -
Dorange, F., Tischer, B. K., Vautherot, J.-F., Osterrieder, N.
(2002). Characterization of Marek's Disease Virus Serotype 1 (MDV-1) Deletion Mutants That Lack UL46 to UL49 Genes: MDV-1 UL49, Encoding VP22, Is Indispensable for Virus Growth. J. Virol.
76: 1959-1970
[Abstract] [Full Text] -
del Rio, T., Werner, H. C., Enquist, L. W.
(2002). The Pseudorabies Virus VP22 Homologue (UL49) Is Dispensable for Virus Growth In Vitro and Has No Effect on Virulence and Neuronal Spread in Rodents. J. Virol.
76: 774-782
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»